Ritanserin, a novel agent targeting the mesenchymal subtype of glioblastomas.

Autor: Audia A; University of Texas M.D. Anderson Cancer Center, Houston, Texas., Bhat KP; University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Jazyk: angličtina
Zdroj: Neuro-oncology [Neuro Oncol] 2018 Jan 22; Vol. 20 (2), pp. 151-152.
DOI: 10.1093/neuonc/nox240
Databáze: MEDLINE